中国临床新医学
中國臨床新醫學
중국림상신의학
Chinese Journal of New Clinical Medicine
2015年
10期
916-919
,共4页
宋志靖%吴建民%李宁%赵彬元%颉旺军%刘强%周强
宋誌靖%吳建民%李寧%趙彬元%頡旺軍%劉彊%週彊
송지정%오건민%리저%조빈원%힐왕군%류강%주강
骶管注射%老年人%下腰段%腰椎间盘突出症%疼痛
骶管註射%老年人%下腰段%腰椎間盤突齣癥%疼痛
저관주사%노년인%하요단%요추간반돌출증%동통
Sacral canal injection%Eldly patients%Lumbarsegment%Lumbar disc herniation%Pain
目的：探讨改良骶管三联注射药物治疗老年人下腰段腰椎间盘突出症的临床效果。方法选取该科2011-11～2014-06住院和门诊的下腰段腰椎间盘突出症患者84例，分为治疗组和对照组各42例。治疗组先采用利多卡因5 ml、地塞米松5 mg、维生素B120.5 mg、42～45℃生理盐水20 ml进行骶管内注射（第一针）；然后再采用利多卡因5 ml、地塞米松5 mg、42～45℃生理盐水10 ml骶管内注射（第2针）。1次／3 d，3次为1个疗程。对照组采用推拿治疗，1次／d，10次为1个疗程。结果两组不同时间的VAS评分之间差异有统计学意义（F时点＝9.76，P时点＝0.00），治疗后10 d的VAS评分值最低；治疗组和对照组的VAS评分之间差异有统计学意义（ F组间＝5.63，P组间＝0.01）；治疗组的VAS评分低于对照组，不同分组不同时间之间存在交互作用（ F组间×时点＝5.44，P组间×时点＝0.01）。治疗组治愈26例，显效14例，无效2例。对照组治愈15例，显效20例，无效7例。治疗组临床疗效优于对照组（Z＝－2.574，P＝0.010）。结论改良骶管注射三联用药治疗老年人下腰段腰椎间盘突出症安全可靠，疗效显著，可在门诊治疗中推广应用。
目的：探討改良骶管三聯註射藥物治療老年人下腰段腰椎間盤突齣癥的臨床效果。方法選取該科2011-11～2014-06住院和門診的下腰段腰椎間盤突齣癥患者84例，分為治療組和對照組各42例。治療組先採用利多卡因5 ml、地塞米鬆5 mg、維生素B120.5 mg、42～45℃生理鹽水20 ml進行骶管內註射（第一針）；然後再採用利多卡因5 ml、地塞米鬆5 mg、42～45℃生理鹽水10 ml骶管內註射（第2針）。1次／3 d，3次為1箇療程。對照組採用推拿治療，1次／d，10次為1箇療程。結果兩組不同時間的VAS評分之間差異有統計學意義（F時點＝9.76，P時點＝0.00），治療後10 d的VAS評分值最低；治療組和對照組的VAS評分之間差異有統計學意義（ F組間＝5.63，P組間＝0.01）；治療組的VAS評分低于對照組，不同分組不同時間之間存在交互作用（ F組間×時點＝5.44，P組間×時點＝0.01）。治療組治愈26例，顯效14例，無效2例。對照組治愈15例，顯效20例，無效7例。治療組臨床療效優于對照組（Z＝－2.574，P＝0.010）。結論改良骶管註射三聯用藥治療老年人下腰段腰椎間盤突齣癥安全可靠，療效顯著，可在門診治療中推廣應用。
목적：탐토개량저관삼련주사약물치료노년인하요단요추간반돌출증적림상효과。방법선취해과2011-11～2014-06주원화문진적하요단요추간반돌출증환자84례，분위치료조화대조조각42례。치료조선채용리다잡인5 ml、지새미송5 mg、유생소B120.5 mg、42～45℃생리염수20 ml진행저관내주사（제일침）；연후재채용리다잡인5 ml、지새미송5 mg、42～45℃생리염수10 ml저관내주사（제2침）。1차／3 d，3차위1개료정。대조조채용추나치료，1차／d，10차위1개료정。결과량조불동시간적VAS평분지간차이유통계학의의（F시점＝9.76，P시점＝0.00），치료후10 d적VAS평분치최저；치료조화대조조적VAS평분지간차이유통계학의의（ F조간＝5.63，P조간＝0.01）；치료조적VAS평분저우대조조，불동분조불동시간지간존재교호작용（ F조간×시점＝5.44，P조간×시점＝0.01）。치료조치유26례，현효14례，무효2례。대조조치유15례，현효20례，무효7례。치료조림상료효우우대조조（Z＝－2.574，P＝0.010）。결론개량저관주사삼련용약치료노년인하요단요추간반돌출증안전가고，료효현저，가재문진치료중추엄응용。
Objective To investigate the clinical effect of modified sacral injection of triple drugs in the treatment of senilelumbar disc herniation.Methods Eighty patients with lower lumbarprotrusion of the discogenic pain were collected in the inpatients and outpatients in our hospital from November 2011 to June 2014 and divided in-to the treatment group(n=42) and the control group(n=42).The treatment group was given lidocaine 5 ml and dexamethasone 5 mg, vitamin B12 0.5 mg, 42~45 ℃20 ml of physiological saline for sacral canal injection, fol-lowed by sacral canal injection with lidocaine 5 ml, dexamethasone 5 mg, 42~45℃10 ml of physiological saline, 1 time every three days, three times as a period of treatment.The control group was given massage therapy, 1 time per day,10 times as a period of treatment.Results There were significant differences in VAS scores between the two groups at different time points(Ftime-point =9.76,Ptime-point=0.00), and the lowest scores occurred on the tenth day af-ter the treatment in both of the two groups.The VAS score of the treatment group was significantly lower than that of the control group(Fbetween-group =5.63, Pbetween-group =0.01).There were interactions between the different groups and the different time points(Fgroup category ×point =5.44, Pgroup category ×point =0.01).26 cases were cured, 14 cases improved and 2 cases invalid in the treatment group, and 15 cases were cured, 20 cases improved and 7 cases invalid in the control group.The clinical curative effect of the treatment group is better than that of the control group(Z=-2.574, P=0.010) .Conclusion Sacral canal injection of triple-drug therapy for elderly patients with lumbar disc herniation is safe and effective.It is suitabale for outpatient treatment.
